期刊文献+

Establishment of mice model with human viral hepatitis B 被引量:3

Establishment of mice model with human viral hepatitis B
下载PDF
导出
摘要 AIM:To establish a mice model of hepatitis B by using HBV-transgenic mice, and to transfer HBV-specific cytotoxic T lymphoo/tes (CTL) induced from syngeneic BALB/c mice immunized by a eukaryotic expression vector containing HBV complete genome DNA.METHODS: HBV DNA was obtained from digested pBR3222HBV and ligated with the vector pcDNA3. Recombinant pcDNA3-HBV was identified by restriction endonuclease assay and transfected into human hepatoma cell line HepG2 with lipofectin. ELISA was used to detect the expression of HBsAg in culture supernatant, and RT-PCR to determine the existence of HBV PreS1 mRNA.BALB/c mice were immunized with pcDNA3-HBV or pcDNA3 by intramuscular injection.ELISA was used to detect the expression of HBsAb in serum. MTT assay was used to measure non-specific or specific proliferation ability and specific killing activity of spleen lymphocytes. Lymphocytes from immunized mice were transferred into HBV-transgenic mice (2.5×10^7 per mouse).Forty-eight hours later,the level of serum protein and transaminase was detected with biochemical method,liver and kidney were sectioned and stained by HE to observe the pathological changes.RESULTS: By enzyme digestion with Eco RI, Xho I and Hind Ⅲ,the recombinant pcDNA3-HBV was verified to contain a single copy of HBV genome,which was inserted in the positive direction.HepG2 cells transfected with the recombinant could stably express PreS1 mRNA and HBsAg.After immunized by pcDNA3-HBV for 4 weeks,HBsAb was detected in the serum of BALB/c mice. The potential of spleen lymphoo/tes for both non-specific and specific proliferation and the specific killing activity against target cells were enhanced. The transgenic mice in model group had no significant changes in the level of serum protein but had an obvious increase of ALT and AST. The liver had obvious pathological changes, while the kidney had no evident damage.CONCLUSION:A eukaryotic expression vector pcDNA3-HBV containing HBV complete genome is constructed successfully. HepG2 cells transfected with the recombinant can express PreS1 mRNA and HBsAg stably.Specific cellular immune response can be induced in mice immunized by pcDNA3-HBV.A mice model of acute hepatitis with HBV has been established. AIM:To establish a mice model of hepatitis B by using HBV-transgenic mice,and to transfer HBV-specific cytotoxic T lymphocytes (CTL) induced from syngeneic BALB/c mice immunized by a eukaryotic expression vector containing HBV complete genome DNA. METHODS:HBV DNA was obtained from digested pBR322- 2HBV and ligated with the vector pcDNA3.Recombinant pcDNA3-HBV was identified by restriction endonuclease assay and transfected into human hepatoma cell line HepG2 with lipofectin.ELISA was used to detect the expression of HBsAg in culture supernatant,and RT-PCR to determine the existence of HBV PreS1 mRNA.BALB/c mice were immunized with pcDNA3-HBV or pcDNA3 by intramuscular injection.ELISA was used to detect the expression of HBsAb in serum.MTT assay was used to measure non-specific or specific proliferation ability and specific killing activity of spleen lymphocytes.Lymphocytes from immunized mice were transferred into HBV-transgenic mice (2.5×10~7 per mouse).Forty-eight hours later,the level of serum protein and transaminase was detected with biochemical method, liver and kidney were sectioned and stained by HE to observe the pathological changes. RESULTS:By enzyme digestion with Eco RI,Xho Ⅰ and Hind Ⅲ,the recombinant pcDNA3-HBV was verified to contain a single copy of HBV genome,which was inserted in the positive direction.HepG2 cells transfected with the recombinant could stably express PreS1 mRNA and HBsAg. After immunized by pcDNA3-HBV for 4 weeks,HBsAb was detected in the serum of BALB/c mice.The potential of spleen lymphocytes for both non-specific and specific proliferation and the specific killing activity against target cells were enhanced.The transgenic mice in model group had no significant changes in the level of serum protein but had an obvious increase of ALT and AST.The liver had obvious pathological changes,while the kidney had no evident damage. CONCLUSION:A eukaryotic expression vector pcDNA3- HBV containing HBV complete genome is constructed successfully.HepG2 cells transfected with the recombinant can express PreS1 mRNA and HBsAg stably.Specific cellular immune response can be induced in mice immunized by pcDNA3-HBV.A mice model of acute hepatitis with HBV has been established.
机构地区 InstituteofImmunology
出处 《World Journal of Gastroenterology》 SCIE CAS CSCD 2004年第6期841-846,共6页 世界胃肠病学杂志(英文版)
基金 Supported by the National Natural Science Foundation of China,No.30070341 the National Natural Science Foundation of China for Young Scholars Abroad,No.30128023
  • 相关文献

参考文献4

二级参考文献125

  • 1[43]Griffiths PD. Interactions between viral and human genes. Rev Med Virol 2002; 12:197-199
  • 2[44]Dean M, Carrington M, O′Brien SJ. Balanced polymorphism selected by genetic versus infectious human disease. Annu Rev Genomics Hum Genet 2002; 3:263-292
  • 3[1]Gu CH, Luo KX. Hepatitis B: Basic biology and clinical science. Second edition. Beijing, People′s Medical Publishing House 2001:1-6
  • 4[2]Iino S. Natural history of hepatitis B and C virus infections. Oncology 2002; 62(Suppl 1): 18-23
  • 5[3]Luo KX. Hepatitis B: Basic biology and clinical science. Second edition. Beijing, People′s Medical Publishing House 2001:56-70
  • 6[4]Ferrari C. Hepatitis B virus immunopathogenesis. Annu Rev Immunol 1995; 13:29-60
  • 7[5]Guidotti LG, Chisari FV. Noncytolytic control of viral infections by the innate and adaptive immune response. Annu Rev Immunol 2001; 19:65-91
  • 8[6]Abel L, Dessein AJ. The impact of host genetics on susceptibility to human infectious diseases. Curr Opin Immunol 1997; 9:509-516
  • 9[7]McNicholl J. Host genes and infectious diseases. Emerg Infect Dis 1998; 4:423-426
  • 10[8]McNicholl JM, Cuenco KT. Host genes and infectious diseases.HIV, other pathogens, and a public health perspective. Am J Prev Med 1999; 16:141-154

共引文献163

同被引文献42

  • 1Grimm CF,Ortmann D,Mohr L,et al.Mouse alpha-fetoprotein-specific DNA-based immunotherapy of hepatocellular carcinoma leads to tumor regression in mice. Gastroenterology . 2000
  • 2Marie-Pierre Bralet Virginie Pichard and Nicolas Ferry.Demonstration of direct lineage between hepatocytes and hepatocellular carcinoma in diethylnitrosamine-treated rats. Hepatology . 2002
  • 3Onishi T,Nouso K,Higashi T,et al.Cellular distribution of telomerase reverse transcriptase in human hepatocellular carcinoma. Journal of Gastroenterology . 2003
  • 4Li YZ,Wang Q,Jiang YF.Establishment of hepatocarcinoma cell line transfected by the B7 gene and its biocharacteristics. Journal of Hepatobiliary Pancreat Disease . 2003
  • 5Blum HE.Molecular therapy and prevention of hepatocellularcarcinoma. Journal of Hepatobiliary Pancreat Disease . 2003
  • 6Lu YY,Li K,Cheng J,WangL,Liu Y,Zhang LX.Cloning and expression of the preS1 gene of hepatitis B virus in yeast cells. Journal of Hepatobiliary Pancreat Disease . 2002
  • 7Sun XY,Wu ZD,Hu JB.Suicide gene therapy of hepatocellular carci-noma and delivery procedure and route of therapeutic gene in vivo. Journal of Hepatobiliary Pancreat Disease . 2002
  • 8John T. Mullen MD,Kenneth K. Tanabe MD.Viral Oncolysis for Malignant Liver Tumors[J]. Annals of Surgical Oncology . 2003 (6)
  • 9Miao CH,Ye X,Thompson AR.High-level factor gene expression in vivo achieved by nonviral liver-specific gene therapy vectors. Human Gene Therapy . 2003
  • 10Ovejero C,Cavard C,Perianin A,Hakvoort T,Vermeulen J,Godard C, et al.Identification of the leukocyte cell-derived che- motaxin 2 as a direct target gene of beta-catenin in the liver. Hepatology . 2004

引证文献3

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部